WVE vs. OSCR
WVE (Wave Life Sciences Ltd.) and OSCR (Oscar Health, Inc.) are both stocks. Both are in the Healthcare sector — WVE in Biotechnology, OSCR in Healthcare Plans. Over the past 5 years, WVE returned -3.18%/yr vs -4.42%/yr for OSCR. At a 0.16 correlation, their price movements are largely independent.
Performance
WVE vs. OSCR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WVE achieves a -66.12% return, which is significantly lower than OSCR's 42.66% return.
WVE
- 1D
- 1.23%
- 1M
- -22.89%
- YTD
- -66.12%
- 6M
- -19.33%
- 1Y
- -11.38%
- 3Y*
- 8.18%
- 5Y*
- -3.18%
- 10Y*
- -9.66%
OSCR
- 1D
- -3.03%
- 1M
- 10.39%
- YTD
- 42.66%
- 6M
- 19.88%
- 1Y
- 43.86%
- 3Y*
- 40.64%
- 5Y*
- -4.42%
- 10Y*
- —
WVE vs. OSCR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WVE Wave Life Sciences Ltd. | -66.12% | 37.43% | 144.95% | -27.86% | 122.93% | -69.34% |
OSCR Oscar Health, Inc. | 42.66% | 6.92% | 46.89% | 271.95% | -68.66% | -77.44% |
Correlation
The correlation between WVE and OSCR is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2021 | 0.16 |
Fundamentals
WVE:
$1.15B
OSCR:
$6.76B
WVE:
-$1.03
OSCR:
-$0.14
WVE:
14.28
OSCR:
0.44
WVE:
2.25
OSCR:
4.06
WVE:
$71.80M
OSCR:
$13.30B
WVE:
$29.09M
OSCR:
$895.79M
WVE:
-$184.40M
OSCR:
$19.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WVE vs. OSCR — Risk / Return Rank
WVE
OSCR
WVE vs. OSCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Wave Life Sciences Ltd. (WVE) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WVE | OSCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.64 | ||
| Sortino ratioReturn per unit of downside risk | -0.09 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.16 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.16 | 0.85 | -1.01 |
| Martin ratioReturn relative to average drawdown | -0.30 | 1.58 | -1.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WVE | OSCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.07 | 0.57 | -0.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | -0.06 | +0.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.10 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | -0.12 | +0.03 |
Drawdowns
WVE vs. OSCR - Drawdown Comparison
The maximum WVE drawdown since its inception was -97.77%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for WVE and OSCR.
Loading charts...
Drawdown Indicators
| WVE | OSCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.77% | -94.15% | -3.62% |
Max Drawdown (1Y)Largest decline over 1 year | -73.30% | -51.71% | -21.59% |
Max Drawdown (3Y)Largest decline over 3 years | -73.30% | -53.39% | -19.91% |
Max Drawdown (5Y)Largest decline over 5 years | -83.53% | -92.65% | +9.12% |
Max Drawdown (10Y)Largest decline over 10 years | -97.77% | — | — |
Current DrawdownCurrent decline from peak | -89.57% | -44.25% | -45.32% |
Average DrawdownAverage peak-to-trough decline | -64.75% | -65.20% | +0.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.53% | 27.81% | +9.72% |
Volatility
WVE vs. OSCR - Volatility Comparison
The current volatility for Wave Life Sciences Ltd. (WVE) is 14.76%, while Oscar Health, Inc. (OSCR) has a volatility of 21.69%. This indicates that WVE experiences smaller price fluctuations and is considered to be less risky than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WVE | OSCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.76% | 21.69% | -6.93% |
Volatility (6M)Calculated over the trailing 6-month period | 123.16% | 42.03% | +81.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 168.77% | 76.70% | +92.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.59% | 80.47% | +34.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 98.98% | 79.71% | +19.27% |
Dividends
WVE vs. OSCR - Dividend Comparison
Neither WVE nor OSCR has paid dividends to shareholders.
Financials
WVE vs. OSCR - Financials Comparison
This section allows you to compare key financial metrics between Wave Life Sciences Ltd. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WVE vs. OSCR - Profitability Comparison
WVE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported a gross profit of 0.00 and revenue of 38.25M. Therefore, the gross margin over that period was 0.0%.
OSCR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 4.65B. Therefore, the gross margin over that period was 0.0%.
WVE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported an operating income of -31.30M and revenue of 38.25M, resulting in an operating margin of -81.8%.
OSCR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported an operating income of 704.09M and revenue of 4.65B, resulting in an operating margin of 15.2%.
WVE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported a net income of -26.09M and revenue of 38.25M, resulting in a net margin of -68.2%.
OSCR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a net income of 679.00M and revenue of 4.65B, resulting in a net margin of 14.6%.
Frequently Asked Questions
WVE and OSCR have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OSCR has higher volatility (21.69%) compared to WVE (14.76%). In terms of maximum drawdown, WVE dropped -97.77% vs OSCR's -94.15%.
OSCR currently has the higher Sharpe Ratio (0.57 vs -0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WVE and OSCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer